1MADILL J J,MULLEN N B,HARRISON B P.Ovarian hyp- erstimulation syndrome: a potentially fatal complication of early pregnancy [ J ].Emerg Med, 21308,35 ( 3 ) : 283-286.
2DOURRON N E,WILLIAMS D B.Prevention and treatment of ovarian hyperstimulation syndrome [ J ]. Semin Reprod Endoerinol, 1996,14 (4) : 355 - 365.
3CHEN S U,CHEN R J,SHIEH J Y,et al.Human chorionic gonadotrophin up regulates expression of myeloid cell leukemia-1 protein in human granulosa-lutein ceils : implication of corpus luteum rescue and ovarian hyperstimulation syndrome [ J ]. Clin Endocrinol Metab, 2010,95(8) :3982-3992.
4CLUROE A D, SYNEK B J. A fatal ease of ovarian hyper- stimulation syndrome with cerebral infarction [ J ]. Pathology, 1995,27 (4) : 344- 346.
5KLEMETYI R, SEV6N T, GISSLER M, et al. Complications of IVF and ovulation induction [ J ]. Hum Reprod, 2005,20 (12) :3293-3300.
6BRINSDEN P R, WADA I, TAN S L, et al. Diagnosis, pre- vention and management of ovarian hyperstimulation syndrome [ J ].Br J Obstet Gynaecol, 1995,102 (10) : 767- 772.
7MATHUR R S, AKANDE A V, KEAY S D, et al. Distinction between early and late ovarian hyperstimulation syndrome [ J ].Fertil Steril, 2000,73 (5) : 901-907.
8LEWIS C G, WARNES G M, WANG X J, et al. Failure of body mass index or body weight to influence markedly the response to ovarian hyperstimulation in normal cycling women [ J ].Fertil Steril, 1990,53 (6) : 1097-1099.
9ENSKOG A, HENRIKSSON M, UNANDER M, et al. Pros- pective study of the clinical and laboratory parameters of patients in whom ovarian hyperstimulation syndrome developed during controlled ovarian hyperstimulation for in vitro fertilization [ J ].Fertil Steril, 1999,71 (5) : 808- 814.
10PAPANIKOLAOU E G, HUMAIDAN P, POLYZOS N P, et al. Identification of the high-risk patient for ovarian hyperstimulation syndrome [ J ]. Semin Reprod Med, 2010, 28(6) :458-462.
2Tozer A,Iles R,Iammarrone E,et al.The effects of coasting on folliculat fluid concentrations of vascular endothelial growth factor in women at risk of developing ovarian hyperstimulation syndrome[J].Hum Reprod,2004,19(3):522-528.
3Fluker M,Hooper W,Yuzpe A.Withholding gonadotropins ("coasting") to minimize the risk of ovarian hyperstimulation during superovulation and in vitro fertilization-embryo transfer cycles[J].Fertil Steril,1999,71(2):294-301.
4Kovacs P,Matyas S,Steven G.Effect of coasting on cycle outcome during in vitro fertilization/intracytoplasmic sperm injection cycles in hyper-responders[J].Fertil Steril,2006,85 (4):913-917.
5Garcia JA,Zuniga A,Pacheco A,et al.Coasting acts through downregulation of VEGF gene expression and protein secretion[J].Hum Reprod,2004,19(7):1530-1538.
6Isaza V,Garcia-Velasco JA,Aragones M,et al.Oocyte and embryo quality after coasting:the experience from oocyte donation[J].Hum Reprod,2002,17(7):1777-1782.
7Benadiva CA,Davis O,Klingman I,et al.Withholding gonadotropin administration is an effective alternative for the prevention of ovarian hyperstimulation sydrome[J].Fertil Steril,1997,67(4):724-727.
8Goldsman MP, Pedram A, Dominguez CE, et al. Increased capillary permeability induced by human follicular fluid: a hypothesis for an ovarian origin of the hyperstimulation syndrome[J]. Fertil Steril, 1995, 63(2):871-872.
9WaUach EE. Preventing ovarian hyperstimulation syndrome: guidance for the clinician[J], Fertil Steril, 2010,94(2):389-400.
10Aboulghar MA, Mansour RT. Ovarian hyperstimulation syndrome: classifications and critical analysis of preventative measures[J]. Hum Reprod Update, 2003, 9(3):275-289.
